Zhejiang Jolly Pharmaceutical Co (SZSE:300181) ROCE % : 22.38% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Zhejiang Jolly Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Jolly Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 22.38%.

Zhejiang Jolly Pharmaceutical Co ROCE % Historical Data

The historical data trend for Zhejiang Jolly Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jolly Pharmaceutical Co ROCE % Chart

Zhejiang Jolly Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

3.25

7.37

11.54

13.16

15.88

Zhejiang Jolly Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															16.44	15.94	23.24	25.12	22.38

Zhejiang Jolly Pharmaceutical Co ROCE % Calculation

Zhejiang Jolly Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	454.265	/	( ( (3642.992 - 754.94)	+	(3627.039 - 794.825) )	/ 2 )
	=	454.265	/	( (2888.052	+	2832.214)	/ 2 )
	=	454.265	/	2860.133
	=	15.88 %

Zhejiang Jolly Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	611.888	/	( ( (3894.078 - 1124.407)	+	(3872.439 - 1174.081) )	/ 2 )
	=	611.888	/	( ( 2769.671	+	2698.358 )	/ 2 )
	=	611.888	/	2734.0145
	=	22.38 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Zhejiang Jolly Pharmaceutical Co (SZSE:300181) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Jolly Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Zhejiang Jolly Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jolly Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Jolly Pharmaceutical Co Ltd (SZSE:300181) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 388 Zhiyuan North Road, Moganshan Economic, Development Zone, Deqing, CHN, 313200

Website

http://www.zuoli.com

Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.

Executives

Shen Ai Ying	Executives
Chen Guo Fen	Executives
Yu You Qiang	Director
Chen Jian	Executives
Zheng Xue Gen	Director
Guo Yin Li	Supervisors
Wang Tao	Executives
Yang Jun De	Director
Chen Rui Xiang	Supervisors
Dong Hong Yu	Directors, executives
Zheng Chao Yi	Directors, executives
Zhu Xiao Ping	Executives
Wu Ying	Securities Affairs Representative

Zhejiang Jolly Pharmaceutical Co Headlines

No Headlines